Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure - The New England Journal of Medicine - 2018
Brief Summary:
Sacubitril-valsartan therapy decreased NT-proBNP concentration compared to enalapril therapy at 4 and 8 weeks, without significantly different rates of medication related adverse effects.Reference: http://www.ncbi.nlm.nih.gov/pubmed/30415601
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you